Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Hong Kong Department of Health

Saturday, February 15, 2025

IASO Biotherapeutics a biopharmaceutical company focused on the discovery development manufacturing and commercialization of innovative cell therapies and biologics today announced that the Hong Kong Department of Health

Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases

Friday, February 14, 2025

Akeso Inc is pleased to announce the acceptance of its Investigational New Drug IND application by the China National Medical Products Administration NMPA for AK a bispecific antibody targeting ILR and ST AK is under investigation

Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

Friday, February 14, 2025

Hanmi Pharmaceutical announced on February that it recently unveiled Countmate a fully automated vial dispensing machine tailored to the unique preferences of the Canada and US market Unlike Korea where medications are commonly dispensed in pouch fo...

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

Friday, February 14, 2025

DAAN Biotherapeutics a leading innovative drug development company specializing in Tcell receptor TCR based therapies has signed an exclusive licensing agreement with LigaChem Biosciences for a novel tumortargeting antibody to advance

TriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients’ Access to Life-Changing Medicines

Thursday, February 13, 2025

TriNetX a global leader in realworld data RWD and realworld evidence RWE solutions has partnered with Fujitsu global ICT company and one of Japans leading electronic health record EHR vendors to form TriNetX Japan KK This groundbreaking joint venture...

OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer

Thursday, February 13, 2025

OnCusp Therapeutics Inc a clinical stage biopharmaceutical company dedicated to transforming cuttingedge preclinical innovation into clinically validated treatments for cancer patients today announced that the US Food and Drug Administration FDA has...

AIM Vaccine Leverages AI to Advance mRNA Vaccine Development mRNA Shingles Vaccine Submits Clinical Trial Application

Thursday, February 13, 2025

AIM Vaccine Co Ltd a leading PRC vaccine company published an announcement on February announced that its independently developed mRNA shingles vaccine has been submitted for clinical trials to the Center for Drug Evaluation CDE of the PRCs Nationa...

SK bioscience Collaborates with WHO to Strengthen Infectious Disease Response … Demonstrates Technological Excellence Through SARS International Standard Material Research

Wednesday, February 12, 2025

SK bioscience has once again demonstrated its leading RD capabilities by successfully collaborating with international organizations to establish an International Standard Material ISM for the SARS SARSCoV virus

BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM

Wednesday, February 12, 2025

BridgeBio Pharma Inca new type of biopharmaceutical company focused on genetic diseases today announced the European Commission has granted marketing authorization in the European Union EU for acoramidis under the brand name BEYONTTRA

New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Approved in Thailand

Wednesday, February 12, 2025

A NEW breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve diseasefree survival in women is now approved for use in Thailand